Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new study examines factors that predicted which black men who have sex with men (MSM) would better stick with the daily Truvada regimen.
The cure rate for Gilead’s new treatment is comparable to what has been seen in people who have only hep C.
An update from the director of the White House Office of National AIDS Policy (ONAP).
HIV Modernization Movement-Indiana (HMM) operates under three guiding principles.
See what happens when people affected by HIV gain access to treatment.
But will there be enough money to keep pushing the dial?
The Phase IIb/III HVTN 702 trial will begin enrollment in southern Africa in the fall.
#WorldHepDay is celebrated on July 28 to help raise awareness for viral liver disease and promote access to treatment across the globe.
The final results of the HPTN 052 study of mixed-HIV-status, opposite-sex partners are in.
“What do we do to fight HIV/AIDS today?” asks activist Daniel Driffin. He offers a few answers.
People with a history of AIDS also face worse health outcomes following a stroke.
Daniel Driffin, 30, is a gay black activist from Atlanta. He’s also a POZ 100 honoree.
The accompanying editorial and press release to recent PARTNER study findings spark concerns from the Prevention Access Campaign.
The FDA seeks public comments on its deferral policy to reduce HIV risk. Currently, gay men must be celibate one year to donate blood.
Constantly adapting the way that the response tries to reach young people is key.
Meanwhile, their rates of other liver health problems are falling.